Plain-English translation of NCT06399952 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a natural history study — meaning researchers will follow people with Baker Gordon Syndrome over time to understand how the condition develops and changes. By collecting medical information, blood samples, skin samples, and sometimes brain imaging, researchers hope to learn more about what causes the condition and identify new ways to help patients in the future.
Baker Gordon Syndrome is a rare genetic disorder that researchers are still learning about. By studying how the condition affects people over time, scientists can discover important patterns and prepare to test new treatments. This groundwork is essential before they can develop and test therapies.
You likely qualify if…
You likely don't qualify if…
You will be asked to share your medical records and complete developmental assessments using standard questionnaires and scales. You will provide a small blood sample for genetic testing and a skin sample for research purposes. Some participants may also have brain imaging (MRI) or electrical brain recordings (EEG), and you may be asked to keep sleep and seizure diaries. Your caregiver will also participate by answering questions about your health and development.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
University of Missouri-Columbia
Enrollment target
~50 participants
Started
April 2024
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
0 Years – 99 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
W. David R Arnold, MD
University of Missouri-Columbia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.